|
G |
A2m |
alpha-2-macroglobulin |
decreases expression |
ISO |
potassium bromate results in decreased expression of A2M mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions increases activity |
EXP |
[potassium bromate co-treated with Caffeine] results in increased activity of ACHE protein; Haloperidol inhibits the reaction [potassium bromate results in increased activity of ACHE protein]; naringin inhibits the reaction [[potassium bromate co-treated with Caffeine] results in increased activity of ACHE protein]; naringin inhibits the reaction [potassium bromate results in increased activity of ACHE protein] |
CTD |
PMID:37865952 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ada |
adenosine deaminase |
multiple interactions increases activity |
EXP |
[potassium bromate co-treated with Caffeine] results in increased activity of ADA protein; Haloperidol inhibits the reaction [potassium bromate results in increased activity of ADA protein]; naringin inhibits the reaction [[potassium bromate co-treated with Caffeine] results in increased activity of ADA protein]; naringin inhibits the reaction [potassium bromate results in increased activity of ADA protein] |
CTD |
PMID:37865952 |
|
NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:152,398,747...152,447,088
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of AGTR2 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AGTR2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr X:116,914,320...116,918,504
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AKR1B10 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
EXP |
potassium bromate results in increased expression of AKR1C2 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation multiple interactions |
EXP |
potassium bromate results in increased phosphorylation of AKT1 protein Squalene inhibits the reaction [potassium bromate results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:33219891 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
decreases expression |
ISO |
potassium bromate results in decreased expression of AMIGO2 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases expression |
ISO |
potassium bromate results in increased expression of APEX1 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:24,144,362...24,146,785
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
ISO |
potassium bromate results in increased expression of APP mRNA |
CTD |
PMID:30008028 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Areg |
amphiregulin |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of AREG mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AREG mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AREG mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of ARG1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
affects expression |
ISO |
potassium bromate affects the expression of ASNS mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression multiple interactions |
EXP ISO |
potassium bromate results in increased expression of ATF3 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA] |
CTD |
PMID:23588252 PMID:27082013 |
|
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atm |
ATM serine/threonine kinase |
decreases expression |
ISO |
potassium bromate results in decreased expression of ATM mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of ATP1B1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr13:79,319,708...79,340,226
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp2b3 |
ATPase plasma membrane Ca2+ transporting 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of ATP2B3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr X:151,216,483...151,289,069
Ensembl chr X:151,216,507...151,286,775
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
ISO |
potassium bromate results in decreased expression of BAAT mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 5:68,647,166...68,656,137
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
potassium bromate results in increased expression of BAX mRNA potassium bromate results in increased expression of BAX protein Squalene promotes the reaction [potassium bromate results in increased expression of BAX protein] |
CTD |
PMID:30559759 PMID:33219891 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of BBOX1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 3:117,277,226...117,326,383
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions |
EXP |
potassium bromate results in increased expression of BCL2 protein Squalene inhibits the reaction [potassium bromate results in increased expression of BCL2 protein] |
CTD |
PMID:33219891 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Blnk |
B-cell linker |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of BLNK mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BLNK mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:249,703,064...249,770,533
Ensembl chr 1:239,753,648...239,821,113
|
|
G |
Bmf |
Bcl2 modifying factor |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of BMF mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BMF mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
increases expression |
ISO |
potassium bromate results in increased expression of BRCA1 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of CA3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Car6 |
carbonic anhydrase 6 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of CAR6 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CAR6 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CAR6 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 5:160,658,104...160,676,644
Ensembl chr 5:160,658,105...160,676,644
|
|
G |
Cars1 |
cysteinyl-tRNA synthetase 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of CARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
EXP |
potassium bromate results in increased expression of CASP3 protein Squalene promotes the reaction [potassium bromate results in increased expression of CASP3 protein] |
CTD |
PMID:33219891 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
decreases activity multiple interactions increases activity |
ISO EXP |
potassium bromate results in decreased activity of CAT protein Arbutin inhibits the reaction [potassium bromate results in decreased activity of CAT protein]; Squalene inhibits the reaction [potassium bromate results in decreased activity of CAT protein]; Taurine inhibits the reaction [potassium bromate results in decreased activity of CAT protein] potassium bromate results in increased activity of CAT protein vanillin inhibits the reaction [potassium bromate results in increased activity of CAT protein] |
CTD |
PMID:22012894 PMID:25213677 PMID:26296324 PMID:27074584 PMID:33219891 PMID:36284482 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression multiple interactions |
EXP ISO |
potassium bromate results in increased expression of CCL20 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CCL20 mRNA] |
CTD |
PMID:23588252 PMID:27082013 |
|
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions increases expression |
ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased expression of CCNB1 protein] |
CTD |
PMID:20067818 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccno |
cyclin O |
decreases expression |
ISO |
potassium bromate results in decreased expression of CCNO mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 2:46,364,074...46,367,113
Ensembl chr 2:44,626,369...44,633,914
|
|
G |
Cdhr1 |
cadherin-related family member 1 |
increases expression |
EXP |
potassium bromate results in increased expression of CDHR1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr16:12,863,696...12,883,579
Ensembl chr16:12,843,437...12,863,396
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases phosphorylation |
ISO |
potassium bromate results in increased phosphorylation of CDK1 protein |
CTD |
PMID:20067818 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions affects expression affects methylation |
ISO EXP |
potassium bromate results in increased expression of CDKN1A mRNA; potassium bromate results in increased expression of CDKN1A protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; Ascorbic Acid inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein] 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; Ascorbic Acid inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; Azacitidine inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein]; trichostatin A inhibits the reaction [potassium bromate results in increased expression of CDKN1A protein] potassium bromate affects the expression of CDKN1A mRNA; potassium bromate affects the expression of CDKN1A protein potassium bromate affects the methylation of CDKN1A gene |
CTD |
PMID:20067818 PMID:23588252 PMID:23811332 PMID:25015661 PMID:30008028 PMID:30559759 More...
|
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cfd |
complement factor D |
decreases expression |
EXP |
potassium bromate results in decreased expression of CFD mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:9,813,150...9,815,053
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
EXP |
potassium bromate results in increased expression of CHAC1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Cldn2 |
claudin 2 |
decreases expression |
ISO |
potassium bromate results in decreased expression of CLDN2 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr X:108,248,383...108,258,847
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Clu |
clusterin |
increases expression |
EXP |
potassium bromate results in increased expression of CLU protein |
CTD |
PMID:23159986 PMID:23588252 PMID:23811332 |
|
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Coch |
cochlin |
decreases expression |
EXP |
potassium bromate results in decreased expression of COCH mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:69,031,167...69,045,109
|
|
G |
Comt |
catechol-O-methyltransferase |
increases expression |
EXP |
potassium bromate results in increased expression of COMT mRNA |
CTD |
PMID:23588252 |
|
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
increases expression |
EXP |
potassium bromate results in increased expression of CSRP3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Cth |
cystathionine gamma-lyase |
increases methylation |
ISO |
potassium bromate results in increased methylation of CTH promoter |
CTD |
PMID:30559759 |
|
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CXCL3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
decreases expression increases expression |
EXP |
potassium bromate results in decreased expression of CYP2C7 mRNA potassium bromate results in increased expression of CYP2C7 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:247,966,295...248,022,393
Ensembl chr 1:237,332,659...237,388,709
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions affects expression |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of CYP2D22 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CYP2D22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of CYP2D22 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression |
ISO |
potassium bromate results in decreased expression of CYP3A4 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddb2 |
damage specific DNA binding protein 2 |
increases expression |
ISO |
potassium bromate results in increased expression of DDB2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:77,185,109...77,207,631
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
potassium bromate results in increased expression of DDIT3 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of DIO3 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of DIO3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:129,285,749...129,286,660
|
|
G |
Dsc1 |
desmocollin 1 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of DSC1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr18:11,774,711...11,831,868
Ensembl chr18:11,502,003...11,528,494
|
|
G |
Dusp2 |
dual specificity phosphatase 2 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of DUSP2 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of DUSP2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 3:135,009,636...135,011,821
Ensembl chr 3:114,556,325...114,558,499
|
|
G |
Egr4 |
early growth response 4 |
multiple interactions affects expression |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of EGR4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of EGR4 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:119,605,358...119,607,817
Ensembl chr 4:118,047,869...118,050,328
|
|
G |
Ercc4 |
ERCC excision repair 4, endonuclease catalytic subunit |
decreases expression |
ISO |
potassium bromate results in decreased expression of ERCC4 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr10:2,926,085...2,958,176
Ensembl chr10:2,419,038...2,448,369 Ensembl chr10:2,419,038...2,448,369
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
affects response to substance multiple interactions |
ISO |
ERCC6 protein affects the susceptibility to potassium bromate veliparib promotes the reaction [ERCC6 protein affects the susceptibility to potassium bromate] |
CTD |
PMID:25136123 |
|
NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
potassium bromate results in increased expression of EREG mRNA |
CTD |
PMID:30008028 |
|
NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
potassium bromate results in increased expression of FAS mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fbxo22 |
F-box protein 22 |
increases expression |
ISO |
potassium bromate results in increased expression of FBXO22 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:64,476,034...64,492,063
Ensembl chr 8:55,579,891...55,596,148
|
|
G |
Fen1 |
flap structure-specific endonuclease 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of FEN1 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:206,844,884...206,850,003
|
|
G |
Fgb |
fibrinogen beta chain |
increases expression |
EXP |
potassium bromate results in increased expression of FGB mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:168,394,916...168,405,979
|
|
G |
Fgl2 |
fibrinogen-like 2 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of FGL2 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of FGL2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:13,710,575...13,716,207
|
|
G |
Fry |
FRY microtubule binding protein |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of FRY mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr12:9,530,360...9,773,391
Ensembl chr12:4,493,891...4,799,116
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
potassium bromate results in increased expression of FTH1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Fzd2 |
frizzled class receptor 2 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of FZD2 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of FZD2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:88,061,988...88,063,898
Ensembl chr10:87,561,326...87,565,334
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions decreases activity |
EXP |
Taurine inhibits the reaction [potassium bromate results in decreased activity of G6PD protein] |
CTD |
PMID:25213677 |
|
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
potassium bromate results in increased expression of GADD45A mRNA |
CTD |
PMID:30008028 PMID:30559759 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression increases methylation |
ISO |
potassium bromate results in increased expression of GCLM mRNA potassium bromate results in increased methylation of GCLM promoter |
CTD |
PMID:30008028 PMID:30559759 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
increases expression |
ISO |
potassium bromate results in increased expression of GCNT3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:79,570,081...79,577,389
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Gpr87 |
G protein-coupled receptor 87 |
increases expression |
ISO |
potassium bromate results in increased expression of GPR87 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:145,589,630...145,608,094
Ensembl chr 2:143,439,735...143,458,190
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases activity multiple interactions |
EXP |
potassium bromate results in increased activity of GPT protein Squalene inhibits the reaction [potassium bromate results in increased activity of GPT protein] |
CTD |
PMID:33219891 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Grifin |
galectin-related inter-fiber protein |
decreases expression |
EXP |
potassium bromate results in decreased expression of GRIFIN mRNA |
CTD |
PMID:23588252 |
|
NCBI chr12:19,194,829...19,196,811
Ensembl chr12:14,080,910...14,082,877
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity multiple interactions |
ISO EXP |
potassium bromate results in decreased activity of GSR protein Squalene inhibits the reaction [potassium bromate results in decreased activity of GSR protein]; Taurine inhibits the reaction [potassium bromate results in decreased activity of GSR protein] |
CTD |
PMID:22012894 PMID:25213677 PMID:33219891 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of GSTA5 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of GSTA5 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 8:87,985,768...87,997,766
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions increases phosphorylation |
ISO EXP |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein; bisphenol A inhibits the reaction [[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein] potassium bromate results in increased phosphorylation of H2AX protein Azacitidine inhibits the reaction [potassium bromate results in increased phosphorylation of H2AX protein]; trichostatin A inhibits the reaction [potassium bromate results in increased phosphorylation of H2AX protein] |
CTD |
PMID:25015661 PMID:25693136 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
increases expression |
EXP |
potassium bromate results in increased expression of HAVCR1 mRNA; potassium bromate results in increased expression of HAVCR1 protein |
CTD |
PMID:23588252 PMID:23811332 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
ceric oxide inhibits the reaction [potassium bromate results in increased expression of HMOX1 mRNA] |
CTD |
PMID:25618551 PMID:30008028 PMID:30559759 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
increases expression decreases expression |
ISO |
potassium bromate results in increased expression of HNF4A mRNA potassium bromate results in decreased expression of HNF4A mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Hp |
haptoglobin |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of HP mRNA [potassium bromate co-treated with bisphenol A] affects the expression of HP mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of HP mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of HP mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of HPGD mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr16:38,996,876...39,034,831
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
increases mutagenesis |
ISO |
potassium bromate results in increased mutagenesis of HPRT1 gene |
CTD |
PMID:19853637 PMID:22539617 |
|
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
increases expression |
EXP |
potassium bromate results in increased expression of IGFBP1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Ikzf2 |
IKAROS family zinc finger 2 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of IKZF2 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IKZF2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:78,495,670...78,640,896
Ensembl chr 9:71,042,440...71,190,867
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of IL18R1 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of IL18R1 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of IL18R1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IL18R1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:50,223,274...50,257,370
Ensembl chr 9:42,727,869...42,760,715
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
EXP ISO |
potassium bromate results in increased expression of IL1B mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of IL1B mRNA] |
CTD |
PMID:23588252 PMID:26296324 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il24 |
interleukin 24 |
increases expression |
EXP |
potassium bromate results in increased expression of IL24 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr13:44,905,362...44,910,760
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of IL6 mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of IL6 mRNA] |
CTD |
PMID:26296324 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kat2b |
lysine acetyltransferase 2B |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:6,799,101...6,903,616
Ensembl chr 9:6,562,288...6,667,064
|
|
G |
Kirrel3 |
kirre like nephrin family adhesion molecule 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of KIRREL3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 8:41,123,692...41,663,528
Ensembl chr 8:32,862,776...33,405,676
|
|
G |
Klf15 |
KLF transcription factor 15 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of KLF15 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of KLF15 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:122,965,807...122,978,374
|
|
G |
Lcn2 |
lipocalin 2 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Lgals12 |
galectin 12 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LGALS12 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:204,832,065...204,842,759
Ensembl chr 1:204,832,065...204,842,759
|
|
G |
Lig3 |
DNA ligase 3 |
decreases expression |
ISO |
potassium bromate results in decreased expression of LIG3 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr10:68,215,371...68,238,705
Ensembl chr10:67,717,812...67,798,414
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
potassium bromate results in increased phosphorylation of and results in increased activity of MAPK1 protein |
CTD |
PMID:20067818 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
potassium bromate results in increased phosphorylation of and results in increased activity of MAPK3 protein |
CTD |
PMID:20067818 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
increases expression |
ISO |
potassium bromate results in increased expression of MDM2 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
potassium bromate results in increased expression of ME1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Med1 |
mediator complex subunit 1 |
decreases phosphorylation |
ISO |
potassium bromate results in decreased phosphorylation of MED1 protein |
CTD |
PMID:25068892 |
|
NCBI chr10:83,641,851...83,685,560
Ensembl chr10:83,145,568...83,189,299
|
|
G |
Mir126a |
microRNA 126a |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR126 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 3:29,813,150...29,813,267
Ensembl chr 3:9,415,063...9,415,180
|
|
G |
Mir134 |
microRNA 134 |
increases expression |
ISO |
potassium bromate results in increased expression of MIR134 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:128,748,908...128,748,980
|
|
G |
Mir137 |
microRNA 137 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR137 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:206,480,881...206,480,982
Ensembl chr 2:206,480,884...206,480,985
|
|
G |
Mir146b |
microRNA 146b |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR146B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:255,144,860...255,144,947
Ensembl chr 1:245,203,438...245,203,525
|
|
G |
Mir193a |
microRNA 193a |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR193A mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:65,170,306...65,170,417
Ensembl chr10:64,672,343...64,672,454
|
|
G |
Mir193b |
microRNA 193b |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR193B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:1,317,742...1,317,824
Ensembl chr10:1,317,742...1,317,824
|
|
G |
Mir205 |
microRNA 205 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR205 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr13:107,564,535...107,564,642
Ensembl chr13:105,035,878...105,035,985
|
|
G |
Mir21 |
microRNA 21 |
increases expression |
ISO |
potassium bromate results in increased expression of MIR21 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir23b |
microRNA 23b |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR23B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr17:1,819,386...1,819,482
Ensembl chr17:1,813,667...1,813,763
|
|
G |
Mir29b1 |
microRNA 29b-1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR29B1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:60,618,334...60,618,414
Ensembl chr 4:59,650,986...59,651,067
|
|
G |
Mir322 |
microRNA 322 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR424 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:132,806,594...132,806,688
Ensembl chr X:132,806,594...132,806,688
|
|
G |
Mir331 |
microRNA 331 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR331 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:30,414,386...30,414,481
Ensembl chr 7:28,527,390...28,527,485
|
|
G |
Mir542 |
microRNA 542 |
decreases expression |
ISO |
potassium bromate results in decreased expression of MIR542 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr X:132,802,623...132,802,701
Ensembl chr X:132,802,623...132,802,701
|
|
G |
Mmp15 |
matrix metallopeptidase 15 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of MMP15 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of MMP15 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr19:9,669,506...9,691,000
Ensembl chr19:9,663,449...9,684,943
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases expression multiple interactions |
EXP |
potassium bromate results in increased expression of MMP2 protein Squalene inhibits the reaction [potassium bromate results in increased expression of MMP2 protein] |
CTD |
PMID:33219891 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions increases expression |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of MT1 mRNA] |
CTD |
PMID:27074584 |
|
NCBI chr19:10,831,959...10,832,975
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Mt2 |
metallothionein 2 |
multiple interactions increases expression |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of MT2 mRNA] |
CTD |
PMID:27074584 |
|
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
increases expression |
EXP |
potassium bromate results in increased expression of MTHFD2 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Muc1 |
mucin 1, cell surface associated |
decreases expression |
ISO |
potassium bromate results in decreased expression of MUC1 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Mutyh |
mutY DNA glycosylase |
decreases expression |
ISO |
potassium bromate results in decreased expression of MUTYH mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 5:135,510,666...135,522,777
Ensembl chr 5:130,274,122...130,286,146
|
|
G |
Myh1 |
myosin heavy chain 1 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:51,885,913...51,909,699
Ensembl chr10:51,885,913...51,946,295
|
|
G |
Myh2 |
myosin heavy chain 2 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:51,856,738...51,883,236
Ensembl chr10:51,856,738...51,883,236
|
|
G |
Mylk3 |
myosin light chain kinase 3 |
decreases expression |
EXP |
potassium bromate results in decreased expression of MYLK3 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr19:37,858,298...37,916,805
Ensembl chr19:21,691,929...21,742,954
|
|
G |
Nebl |
nebulette |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NEBL mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr17:80,113,891...80,466,331
Ensembl chr17:80,118,543...80,466,210
|
|
G |
Npr3 |
natriuretic peptide receptor 3 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NPR3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:60,870,594...60,932,955
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
potassium bromate results in increased expression of NQO1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
decreases response to substance increases response to substance |
ISO |
OGG1 gene mutant form results in decreased susceptibility to potassium bromate OGG1 protein results in increased susceptibility to potassium bromate |
CTD |
PMID:25693136 PMID:34196753 |
|
NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Ostn |
osteocrin |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of OSTN mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr11:73,442,167...73,478,498
Ensembl chr11:73,442,487...73,468,603
|
|
G |
Pde5a |
phosphodiesterase 5A |
increases activity multiple interactions |
EXP |
potassium bromate results in increased activity of PDE5A protein [potassium bromate co-treated with Caffeine] results in increased activity of PDE5A protein; Haloperidol inhibits the reaction [potassium bromate results in increased activity of PDE5A protein]; naringin inhibits the reaction [[potassium bromate co-treated with Caffeine] results in increased activity of PDE5A protein]; naringin inhibits the reaction [potassium bromate results in increased activity of PDE5A protein] |
CTD |
PMID:37865952 |
|
NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:210,858,063...210,999,701
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
decreases expression |
ISO |
potassium bromate results in decreased expression of PHGDH mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Plch2 |
phospholipase C, eta 2 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of PLCH2 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 5:165,544,209...165,613,769
Ensembl chr 5:165,544,200...165,602,356
|
|
G |
Pnkp |
polynucleotide kinase 3'-phosphatase |
decreases expression |
ISO |
potassium bromate results in decreased expression of PNKP mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 1:104,476,801...104,483,409
Ensembl chr 1:95,341,620...95,346,920
|
|
G |
Ppm1d |
protein phosphatase, Mg2+/Mn2+ dependent, 1D |
increases expression |
ISO |
potassium bromate results in increased expression of PPM1D mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:70,670,026...70,706,030
Ensembl chr10:70,172,603...70,208,607
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
decreases methylation |
ISO |
potassium bromate results in decreased methylation of PPP1R15A promoter |
CTD |
PMID:30559759 |
|
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Prg4 |
proteoglycan 4 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of PRG4 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of PRG4 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PRG4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PRG4 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr13:65,037,363...65,054,764
Ensembl chr13:62,487,257...62,504,119
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
ISO |
potassium bromate results in increased expression of PTGS2 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of PTGS2 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PTGS2 mRNA]; vanillin inhibits the reaction [potassium bromate results in increased expression of PTGS2 mRNA] |
CTD |
PMID:26296324 PMID:27082013 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of PTPN22 mRNA [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PTPN22 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 2:194,055,165...194,103,209
Ensembl chr 2:191,366,808...191,414,779
|
|
G |
Rab3gap2 |
RAB3 GTPase activating non-catalytic protein subunit 2 |
increases expression |
EXP |
potassium bromate results in increased expression of RAB3GAP2 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr13:99,288,984...99,362,817
Ensembl chr13:96,757,460...96,829,478
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases expression |
EXP |
Squalene inhibits the reaction [potassium bromate results in increased expression of RELA protein] |
CTD |
PMID:33219891 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ren |
renin |
increases expression |
EXP |
potassium bromate results in increased expression of REN1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr13:47,348,312...47,359,539
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Retn |
resistin |
decreases expression |
EXP |
potassium bromate results in decreased expression of RETN mRNA |
CTD |
PMID:23588252 |
|
NCBI chr12:6,508,653...6,511,115
Ensembl chr12:1,710,881...1,712,620
|
|
G |
Robo3 |
roundabout guidance receptor 3 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of ROBO3 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of ROBO3 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ROBO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of ROBO3 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 8:45,322,323...45,340,466
Ensembl chr 8:37,133,916...37,151,315
|
|
G |
Rps27l |
ribosomal protein S27-like |
increases expression |
ISO |
potassium bromate results in increased expression of RPS27L mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 8:76,443,658...76,448,593
Ensembl chr 8:67,562,483...67,567,418 Ensembl chr12:67,562,483...67,567,418 Ensembl chr 2:67,562,483...67,567,418
|
|
G |
Rrm2b |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
increases expression |
ISO |
potassium bromate results in increased expression of RRM2B mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 7:70,962,008...70,993,726
Ensembl chr 7:69,078,291...69,108,633
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
increases expression |
EXP |
potassium bromate results in increased expression of S100A8 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:176,167,124...176,167,643
|
|
G |
S100a9 |
S100 calcium binding protein A9 |
decreases expression |
EXP |
potassium bromate results in decreased expression of S100A9 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:176,190,361...176,193,230
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
EXP |
potassium bromate results in decreased expression of SCD1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sertad1 |
SERTA domain containing 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SERTAD1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 1:91,903,297...91,906,565
Ensembl chr 1:82,775,252...82,779,091
|
|
G |
Sesn1 |
sestrin 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SESN1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr20:46,876,918...46,970,010
Ensembl chr20:45,294,871...45,387,697
|
|
G |
Sfn |
stratifin |
increases expression |
ISO |
potassium bromate results in increased expression of SFN mRNA |
CTD |
PMID:30008028 PMID:30559759 |
|
NCBI chr 5:151,110,582...151,111,854
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Slc26a4 |
solute carrier family 26 member 4 |
decreases expression |
EXP |
potassium bromate results in decreased expression of SLC26A4 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 6:53,835,102...53,873,968
Ensembl chr 6:48,107,588...48,145,703
|
|
G |
Slc26a7 |
solute carrier family 26 member 7 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SLC26A7 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 5:32,681,653...32,819,110
Ensembl chr 5:27,887,042...28,021,658
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
potassium bromate results in increased expression of SLC7A11 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
increases expression |
ISO |
potassium bromate results in increased expression of SLC7A5 mRNA |
CTD |
PMID:30008028 |
|
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
affects expression multiple interactions |
ISO |
potassium bromate affects the expression of SLCO2B1 mRNA [potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of SLCO2B1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 1:163,371,410...163,419,412
Ensembl chr 1:153,959,293...154,007,353
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases activity multiple interactions decreases activity |
ISO EXP |
potassium bromate results in increased activity of SOD1 protein Arbutin inhibits the reaction [potassium bromate results in decreased activity of SOD1 protein] |
CTD |
PMID:22012894 PMID:36284482 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions increases expression |
ISO |
ceric oxide inhibits the reaction [potassium bromate results in increased expression of SOD2 mRNA] |
CTD |
PMID:25618551 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spata22 |
spermatogenesis associated 22 |
decreases expression |
EXP |
potassium bromate results in decreased expression of SPATA22 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr10:57,945,272...57,963,081
Ensembl chr10:57,932,187...57,963,081
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
EXP ISO |
potassium bromate results in increased expression of SPP1 mRNA; potassium bromate results in increased expression of SPP1 protein |
CTD |
PMID:23588252 PMID:23811332 PMID:30008028 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SQSTM1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
potassium bromate results in increased expression of SRXN1 mRNA |
CTD |
PMID:22003191 PMID:30008028 |
|
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
increases expression |
EXP |
potassium bromate results in increased expression of SULT2A1 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr 1:84,582,011...84,639,001
Ensembl chr 1:74,911,100...75,508,134
|
|
G |
Tigar |
TP53 induced glycolysis regulatory phosphatase |
increases expression |
ISO |
potassium bromate results in increased expression of TIGAR mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 4:161,613,306...161,632,248
Ensembl chr 4:159,927,139...159,946,029 Ensembl chr 6:159,927,139...159,946,029
|
|
G |
Tk1 |
thymidine kinase 1 |
increases mutagenesis |
ISO |
potassium bromate results in increased mutagenesis of TK1 gene |
CTD |
PMID:19853637 |
|
NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,031,521...103,046,920
|
|
G |
Tmem163 |
transmembrane protein 163 |
decreases expression |
EXP |
potassium bromate results in decreased expression of TMEM163 mRNA |
CTD |
PMID:23588252 |
|
NCBI chr13:41,520,595...41,693,938
Ensembl chr13:38,968,101...39,141,452
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO |
vanillin inhibits the reaction [potassium bromate results in increased expression of TNF mRNA] |
CTD |
PMID:26296324 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf9 |
TNF superfamily member 9 |
increases expression |
ISO |
potassium bromate results in increased expression of TNFSF9 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
|
|
G |
Tns1 |
tensin 1 |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of TNS1 mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of TNS1 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 9:82,941,068...83,152,007
Ensembl chr 9:75,495,814...75,703,225
|
|
G |
Top3b |
DNA topoisomerase III beta |
decreases expression |
ISO |
potassium bromate results in decreased expression of TOP3B mRNA |
CTD |
PMID:22539617 |
|
NCBI chr11:97,601,223...97,629,678
Ensembl chr11:84,097,026...84,125,392
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases phosphorylation |
ISO EXP |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [potassium bromate results in increased phosphorylation of TP53 protein]; Ascorbic Acid inhibits the reaction [potassium bromate results in increased phosphorylation of TP53 protein] |
CTD |
PMID:20067818 PMID:25015661 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
increases methylation increases expression |
ISO |
potassium bromate results in increased methylation of TP53INP1 promoter potassium bromate results in increased expression of TP53INP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:24,260,568...24,267,968
|
|
G |
Triap1 |
TP53 regulated inhibitor of apoptosis 1 |
increases expression |
ISO |
potassium bromate results in increased expression of TRIAP1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr12:46,928,273...46,930,766
Ensembl chr12:41,267,549...41,270,042
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
EXP ISO |
potassium bromate results in increased expression of TRIB3 mRNA |
CTD |
PMID:23588252 PMID:30008028 |
|
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Ubd |
ubiquitin D |
increases expression |
EXP |
potassium bromate results in increased expression of UBD mRNA |
CTD |
PMID:23588252 |
|
NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions increases expression |
EXP |
Squalene inhibits the reaction [potassium bromate results in increased expression of VEGFA protein] |
CTD |
PMID:33219891 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vit |
vitrin |
multiple interactions |
ISO |
[potassium bromate co-treated with bisphenol A] affects the expression of VIT mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of VIT mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr 6:22,198,095...22,317,758
Ensembl chr 6:16,445,955...16,565,665
|
|
G |
Wars1 |
tryptophanyl-tRNA synthetase 1 |
decreases expression |
ISO |
potassium bromate results in decreased expression of WARS1 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 6:133,540,463...133,571,645
Ensembl chr 6:127,776,090...127,807,269
|
|
G |
Wfdc17 |
WAP four-disulfide core domain 17 |
multiple interactions |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of WFDC17 mRNA] |
CTD |
PMID:27082013 |
|
NCBI chr10:69,059,451...69,060,298
Ensembl chr10:68,561,954...68,562,801
|
|
G |
Xdh |
xanthine dehydrogenase |
increases activity multiple interactions |
EXP |
potassium bromate results in increased activity of XDH protein Taurine inhibits the reaction [potassium bromate results in increased activity of XDH protein] |
CTD |
PMID:25213677 |
|
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
decreases expression |
ISO |
potassium bromate results in decreased expression of XRCC3 mRNA |
CTD |
PMID:22539617 |
|
NCBI chr 6:136,684,558...136,694,822
Ensembl chr 6:130,863,959...130,872,444
|
|
G |
Xrcc6 |
X-ray repair cross complementing 6 |
multiple interactions increases response to substance |
ISO |
[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AGTR2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AREG mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ATF3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CAR6 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of CYP2D22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of DIO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of FZD2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of GSTA5 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of HP mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of IL18R1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of MMP15 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PRG4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of PTGS2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of ROBO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of TNS1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CAR6 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CCL20 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of CXCL3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of DSC1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of EGR4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of FRY mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of HCAR2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of HPGD mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LGALS12 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of MYH2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NEBL mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of NPR3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of OSTN mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of PLCH2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SAA3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of SLC26A7 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of WFDC17 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AKR1B10 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of AREG mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BLNK mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of BMF mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of CYP2D22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of DUSP2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of EGR4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of FGL2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of GSTA5 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of HP mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IKZF2 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of IL18R1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of KLF15 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PRG4 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of PTPN22 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of ROBO3 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of SLCO2B1 mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of VIT mRNA]; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein; bisphenol A inhibits the reaction [[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AX protein] |
CTD |
PMID:25693136 PMID:27082013 |
|
NCBI chr 7:115,423,026...115,443,884
Ensembl chr 7:113,543,057...113,563,762
|
|
G |
Zmat3 |
zinc finger, matrin type 3 |
increases expression |
ISO |
potassium bromate results in increased expression of ZMAT3 mRNA |
CTD |
PMID:30559759 |
|
NCBI chr 2:117,034,517...117,066,141
Ensembl chr 2:115,106,966...115,136,863
|
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[sodium bromate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA |
CTD |
PMID:29594315 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
|
|